← Respiratory Pharmacology
SAMANBRC High Yield5/5 Importance

Ipratropium Respiratory Pharmacology Guide

The complete learning guide for class, mechanism, indications, adverse effects, kinetics, exam traps, and NBRC-style respiratory pharmacology.

Ipratropium bromide is a short-acting muscarinic antagonist (SAMA) that produces bronchodilation by blocking acetylcholine-mediated airway constriction. It is primarily used for COPD maintenance therapy and as adjunctive therapy with albuterol during acute asthma and COPD exacerbations.

Clinical Pharmacology

Understand the medication before memorizing it

Start with mechanism, clinical pearls, onset, peak, duration, and deeper pharmacology explanations so the rest of the page has context.

Mechanism

How Ipratropium works

Blocks muscarinic receptors in the airway, especially M3-mediated bronchoconstriction, reducing acetylcholine-driven bronchial smooth muscle contraction.

Clinical Pearl

What to remember

In acute COPD exacerbations, ipratropium is commonly paired with albuterol for additive bronchodilation.

Kinetics

Onset, peak, and duration

1

Onset

About 15 minutes

2

Peak

1 to 2 hours

3

Duration

4 to 6 hours

Overview

Clinical overview

Ipratropium bromide is a short-acting muscarinic antagonist (SAMA) that produces bronchodilation by blocking acetylcholine-mediated airway constriction. It is primarily used for COPD maintenance therapy and as adjunctive therapy with albuterol during acute asthma and COPD exacerbations.

Class

Medication class explained

Short-acting muscarinic antagonists block parasympathetic stimulation of the airways. Unlike beta agonists, they reduce bronchoconstriction by preventing acetylcholine from activating muscarinic receptors on bronchial smooth muscle.

Mechanism

Mechanism deep dive

Ipratropium competitively antagonizes M1, M2 and especially M3 muscarinic receptors throughout the airway. Blocking M3 receptors prevents phospholipase-C activation, IP3 formation, intracellular calcium release and subsequent bronchial smooth muscle contraction. Because the drug is a quaternary ammonium compound, systemic absorption and CNS penetration remain extremely low.

Receptors

Receptor physiology

Ipratropium competitively blocks muscarinic M1, M2 and M3 receptors throughout the airways. Therapeutically, M3 blockade is most important because acetylcholine normally activates phospholipase C, generating IP3 and increasing intracellular calcium within bronchial smooth muscle. Blocking this pathway decreases calcium-mediated contraction, producing bronchodilation and reducing mucus secretion. Because ipratropium is a quaternary ammonium compound, systemic absorption is minimal and it does not significantly cross the blood-brain barrier.

Use

Rescue vs controller role

Ipratropium should not be considered a rescue medication by itself. During severe asthma or COPD exacerbations it is combined with albuterol (DuoNeb or Combivent) because muscarinic blockade and beta-2 agonism produce additive bronchodilation. Stable COPD maintenance increasingly favors LAMA therapy, although ipratropium remains useful in selected patients.

Kinetics

Pharmacokinetics

Bronchodilation begins within approximately 3 to 15 minutes, peaks at 1 to 2 hours and generally lasts 4 to 6 hours. Less than 10 percent of an inhaled dose reaches systemic circulation. Oral absorption is extremely poor, protein binding is low, and most absorbed drug is eliminated by the kidneys. The limited systemic exposure explains the relatively low incidence of systemic anticholinergic adverse effects.

Administration

Dosing and administration

COPD maintenance therapy is typically 2 inhalations of Atrovent HFA four times daily or 500 mcg nebulized every 6 to 8 hours. During acute asthma or COPD exacerbations, 500 mcg nebulized ipratropium is administered every 20 minutes for three doses in combination with high-dose albuterol, followed by intermittent dosing as clinically indicated.

Safety

Safety warnings

Avoid ocular exposure because accidental administration into the eyes may precipitate acute narrow-angle glaucoma. Use cautiously in patients with urinary retention, bladder outlet obstruction or benign prostatic hyperplasia. Rare paradoxical bronchospasm and hypersensitivity reactions require immediate discontinuation.

Interactions

Drug interactions

Concurrent anticholinergic medications may increase dry mouth, urinary retention and blurred vision. Ipratropium is routinely combined with beta-2 agonists such as albuterol because their mechanisms are complementary. Do not mix preservative-containing ipratropium solutions with cromolyn in the same nebulizer.

Monitoring

Monitoring recommendations

Monitor improvement in wheezing, dyspnea, FEV1, work of breathing and bronchodilator response. Assess inhaler or nebulizer technique, evaluate for urinary retention and ocular symptoms, and monitor frequency of rescue bronchodilator use.

Clinical Practice

How this medication is used at the bedside

Review common indications, expected adverse effects, contraindications, cautions, and safety issues in a clinically useful order.

Quick facts

Subclass
SAMA
NBRC importance
5/5
Difficulty
1/5
Brands
Atrovent
5/5
NBRC importance
23
Study facts
62
Practice questions
2026
Updated

Common indications

  • COPD bronchospasm
  • COPD exacerbation when combined with SABA
  • Adjunct therapy in severe asthma exacerbation

Adverse effects

  • Dry mouth
  • Cough
  • Throat irritation
  • Blurred vision if aerosol contacts eyes
  • Urinary retention
  • Paradoxical bronchospasm

Contraindications

  • Hypersensitivity to ipratropium, atropine derivatives, or formulation components

Cautions and safety issues

  • Use caution with narrow-angle glaucoma
  • Use caution with urinary retention or prostatic hyperplasia
  • Avoid spraying into eyes

RT & NBRC Mastery

Respiratory therapy exam and bedside mastery

Move from reference knowledge into board-style reasoning, adaptive practice, common distractors, and high-yield clinical scenarios.

NBRC-style question

NBRC-style pharmacology review

A patient scenario involves copd exacerbation treated with saba plus sama. Which medication concept should the respiratory therapy student recognize?

High-yield answer

Ipratropium belongs to Short-Acting Muscarinic Antagonists.

Interactive practice

The Adaptive Exam Simulator

Use the complete guide on this page to learn the medication, then switch into the adaptive simulator to test yourself with scored practice, missed-concept review, and NBRC-style clinical reasoning.

ClassPractice
MechanismPractice
Clinical usePractice
Adverse effectsPractice
ScenarioPractice
Launch Adaptive Practice

Common Exam Traps

These are the answer choices, mechanisms, or medication classes most commonly confused with this medication on RT school and NBRC-style exams.

  • Short-acting beta agonist
  • Long-acting muscarinic antagonist
  • Inhaled corticosteroid
  • Stimulates beta-2 receptors
  • Primary rescue medication for exercise-induced bronchospasm

High-Yield Clinical Scenarios

  • COPD exacerbation treated with SABA plus SAMA
  • Severe asthma exacerbation as adjunct bronchodilator
  • COPD maintenance symptom control

Clinical decision points

  • Combine with albuterol for severe exacerbations.
  • Avoid spraying into the eyes.
  • Monitor patients with urinary retention.
  • Preferred over beta agonist alone in many COPD exacerbations.
  • Not a replacement for inhaled corticosteroids in asthma.

Expanded exam traps

  • Confusing SAMA with LAMA.
  • Choosing ipratropium as sole rescue therapy.
  • Believing it is an anti-inflammatory medication.
  • Forgetting narrow-angle glaucoma precautions.
  • Confusing M3 blockade with beta-2 stimulation.

Quiz opportunities

  • SAMA identification
  • Receptor physiology
  • COPD guideline questions
  • Drug comparison
  • Clinical scenario interpretation

Guidelines

Guideline-based clinical context

Connect medication facts to the larger respiratory care guidelines, disease-state recommendations, and clinical decision frameworks.

Guidelines

Guideline summary

fda

Approved for maintenance treatment of bronchospasm associated with COPD.

aarc

Teach proper inhaler technique, priming, slow inspiration and avoidance of ocular exposure.

gina

Add inhaled ipratropium to repeated albuterol treatments during the first hour of moderate-to-severe asthma exacerbations.

gold

Use SABA with or without SAMA during acute COPD exacerbations. LAMA therapy is preferred for chronic maintenance.

Study Tools

Practice, recall, and retention

Use mini cases, flashcards, FAQs, and related concepts to turn the medication page into a high-retention study experience.

Clinical application

Mini cases

COPD Exacerbation

Patient presents with severe wheezing and receives DuoNeb.

NBRC Exam

Question asks which medication blocks muscarinic receptors.

Eye Pain

Patient develops unilateral eye pain after nebulizer mask treatment.

Flashcards

High-yield flashcards

Drug class?

Short-acting muscarinic antagonist (SAMA).

Primary receptor blocked?

Muscarinic M3 receptor.

Most common combination medication?

Albuterol.

Most common side effect?

Dry mouth.

High-yield contraindication?

Avoid ocular exposure because of glaucoma risk.

FAQ

Common questions

Is ipratropium a rescue inhaler?

No. It is primarily a maintenance bronchodilator and is most effective when combined with albuterol during acute exacerbations.

What class is ipratropium?

Short-acting muscarinic antagonist (SAMA).

Can ipratropium be given with albuterol?

Yes. DuoNeb and Combivent combine both medications because they produce additive bronchodilation.

What is the most common side effect?

Dry mouth.

Why avoid spraying it into the eyes?

It can precipitate acute narrow-angle glaucoma.

Knowledge graph

Related concepts

Also known as

AtroventAtrovent HFAIpratropium BromideIPRIPB

Related conditions

COPDChronic bronchitisEmphysemaAsthma exacerbationBronchospasmAllergic rhinitisNonallergic rhinitis

Related classes

SAMALAMASABALABAICS

Related devices

Metered-dose inhalerNebulizerSpacerNasal spray

Related guidelines

GOLDGINAAARC

Practice Questions

Complete question bank

Work through 62 board-style and clinical reasoning questions for this medication, organized by concept area.

Complete Learning Guide

Ipratropium practice questions and explanations

These board-style questions are part of the complete learning guide. Answers and explanations are visible here for broad review and SEO, while the adaptive simulator provides the true testing experience.

62
Questions
Medication Class (10)Mechanism of Action (10)Indications and Clinical Use (10)Contraindications, Safety, and Interactions (10)Adverse Effects (12)Clinical Scenarios and NBRC Reasoning (10)

Question group

Medication Class

10 questions
Question 1Difficulty 1/5

Atrovent is classified as which medication class?

  1. A.Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).
  2. B.LABA
  3. C.SABA
  4. D.Systemic corticosteroid

Correct answer

Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).

Explanation

Ipratropium is classified as a short-acting muscarinic antagonist (SAMA). It blocks muscarinic receptors to produce bronchodilation.

Question 2Difficulty 1/5

Which pharmacologic class does ipratropium belong to?

  1. A.Short-Acting Muscarinic Antagonist (SAMA)
  2. B.Long-Acting Muscarinic Antagonist (LAMA)
  3. C.Short-Acting Beta Agonist (SABA)
  4. D.Inhaled Corticosteroid (ICS)

Correct answer

Short-Acting Muscarinic Antagonist (SAMA)

Explanation

Ipratropium is the prototype short-acting muscarinic antagonist.

Question 3Difficulty 1/5

Ipratropium is best classified as what type of bronchodilator?

  1. A.Anticholinergic bronchodilator
  2. B.Beta-2 agonist
  3. C.Inhaled corticosteroid
  4. D.Leukotriene inhibitor

Correct answer

Anticholinergic bronchodilator

Explanation

Ipratropium produces bronchodilation through muscarinic receptor blockade.

Question 4Difficulty 1/5

Which drug class does Ipratropium belong to?

  1. A.Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).
  2. B.Long-Acting Muscarinic Antagonist (LAMA)
  3. C.Short-Acting Beta Agonist (SABA)
  4. D.Inhaled Corticosteroid (ICS)

Correct answer

Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).

Explanation

Ipratropium is classified as a short-acting muscarinic antagonist (SAMA). It blocks muscarinic receptors to produce bronchodilation.

Question 5Difficulty 2/5

Which autonomic nervous system pathway is primarily inhibited by ipratropium?

  1. A.Parasympathetic nervous system
  2. B.Sympathetic nervous system
  3. C.Somatic nervous system
  4. D.Central nervous system

Correct answer

Parasympathetic nervous system

Explanation

Ipratropium blocks parasympathetic cholinergic bronchoconstriction.

Question 6Difficulty 2/5

Which pharmacologic class best describes Atrovent?

  1. A.Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).
  2. B.LAMA
  3. C.LABA
  4. D.ICS

Correct answer

Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).

Explanation

Ipratropium is classified as a short-acting muscarinic antagonist (SAMA). It blocks muscarinic receptors to produce bronchodilation.

Question 7Difficulty 2/5

Ipratropium belongs to which bronchodilator family?

  1. A.Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).
  2. B.Beta agonists
  3. C.Corticosteroids
  4. D.Methylxanthines

Correct answer

Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).

Explanation

Ipratropium is classified as a short-acting muscarinic antagonist (SAMA). It blocks muscarinic receptors to produce bronchodilation.

Question 8Difficulty 2/5

Which medication is considered a SAMA?

  1. A.Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).
  2. B.Tiotropium
  3. C.Formoterol
  4. D.Budesonide

Correct answer

Ipratropium is a Short-Acting Muscarinic Antagonist (SAMA).

Explanation

Ipratropium is classified as a short-acting muscarinic antagonist (SAMA). It blocks muscarinic receptors to produce bronchodilation.

Question 9Difficulty 2/5

Compared with tiotropium, ipratropium is classified as:

  1. A.A short-acting muscarinic antagonist
  2. B.A long-acting muscarinic antagonist
  3. C.A long-acting beta agonist
  4. D.A rescue beta agonist

Correct answer

A short-acting muscarinic antagonist

Explanation

Tiotropium is a LAMA while ipratropium is a SAMA.

Question 10Difficulty 3/5

Which medication is in the SAME drug class as ipratropium?

  1. A.Oxitropium
  2. B.Albuterol
  3. C.Formoterol
  4. D.Budesonide

Correct answer

Oxitropium

Explanation

Both oxitropium and ipratropium are short-acting antimuscarinic bronchodilators.

Question group

Mechanism of Action

10 questions
Question 1Difficulty 1/5

Which autonomic pathway does ipratropium inhibit?

  1. A.Parasympathetic nervous system
  2. B.Sympathetic nervous system
  3. C.Somatic nervous system
  4. D.Central nervous system

Correct answer

Parasympathetic nervous system

Explanation

Ipratropium blocks parasympathetic cholinergic signaling within the airways.

Question 2Difficulty 1/5

Which neurotransmitter does ipratropium oppose?

  1. A.Acetylcholine
  2. B.Norepinephrine
  3. C.Dopamine
  4. D.Serotonin

Correct answer

Acetylcholine

Explanation

Ipratropium competitively blocks acetylcholine at muscarinic receptors.

Question 3Difficulty 1/5

What is the primary mechanism of ipratropium?

  1. A.Blocks muscarinic receptors
  2. B.Stimulates beta-2 receptors
  3. C.Inhibits phosphodiesterase
  4. D.Suppresses airway inflammation

Correct answer

Blocks muscarinic receptors

Explanation

Ipratropium competitively blocks muscarinic receptors to reduce cholinergic bronchoconstriction.

Question 4Difficulty 1/5

Ipratropium primarily decreases:

  1. A.Cholinergic bronchoconstriction
  2. B.Airway inflammation
  3. C.Pulmonary edema
  4. D.Pulmonary fibrosis

Correct answer

Cholinergic bronchoconstriction

Explanation

Its primary action is reducing vagally mediated bronchoconstriction.

Question 5Difficulty 1/5

Blocking M3 receptors causes:

  1. A.Bronchodilation
  2. B.Bronchoconstriction
  3. C.Pulmonary vasoconstriction
  4. D.Increased mucus production

Correct answer

Bronchodilation

Explanation

Reduced calcium-mediated smooth muscle contraction produces bronchodilation.

Question 6Difficulty 2/5

Why does ipratropium have minimal CNS effects?

  1. A.It poorly crosses the blood-brain barrier
  2. B.It is rapidly metabolized in the brain
  3. C.It activates CNS muscarinic receptors
  4. D.It is highly lipophilic

Correct answer

It poorly crosses the blood-brain barrier

Explanation

Its quaternary ammonium structure prevents significant CNS penetration.

Question 7Difficulty 2/5

Why is ipratropium commonly combined with albuterol?

  1. A.They produce additive bronchodilation through different mechanisms
  2. B.Both suppress airway inflammation
  3. C.Both are corticosteroids
  4. D.Both inhibit phosphodiesterase

Correct answer

They produce additive bronchodilation through different mechanisms

Explanation

Muscarinic blockade and beta-2 stimulation complement each other.

Question 8Difficulty 2/5

Which receptor produces most of ipratropium's bronchodilator effect?

  1. A.M3 receptor
  2. B.M2 receptor
  3. C.Beta-1 receptor
  4. D.Beta-2 receptor

Correct answer

M3 receptor

Explanation

M3 blockade decreases bronchial smooth muscle contraction.

Question 9Difficulty 2/5

Why are systemic anticholinergic effects relatively uncommon?

  1. A.Minimal systemic absorption
  2. B.Rapid hepatic metabolism
  3. C.Protein binding exceeds 99%
  4. D.Drug remains entirely in plasma

Correct answer

Minimal systemic absorption

Explanation

The quaternary ammonium structure limits systemic absorption.

Question 10Difficulty 3/5

Which second messenger pathway is reduced after M3 blockade?

  1. A.IP3-mediated calcium release
  2. B.cAMP production
  3. C.Nitric oxide synthesis
  4. D.Sodium influx

Correct answer

IP3-mediated calcium release

Explanation

Blocking M3 receptors prevents PLC activation and intracellular calcium release.

Question group

Indications and Clinical Use

10 questions
Question 1Difficulty 1/5

Which condition is FDA-approved for inhaled ipratropium maintenance therapy?

  1. A.COPD
  2. B.Pulmonary fibrosis
  3. C.Pulmonary embolism
  4. D.Acute respiratory distress syndrome

Correct answer

COPD

Explanation

Ipratropium is FDA-approved for maintenance treatment of bronchospasm associated with COPD.

Question 2Difficulty 1/5

Which medication is frequently combined with ipratropium during COPD exacerbations?

  1. A.Albuterol
  2. B.Budesonide
  3. C.Prednisone
  4. D.Montelukast

Correct answer

Albuterol

Explanation

DuoNeb combines albuterol with ipratropium for additive bronchodilation.

Question 3Difficulty 1/5

Which patient is most likely to benefit from scheduled ipratropium therapy?

  1. A.A patient with chronic COPD
  2. B.A patient with pulmonary fibrosis
  3. C.A patient with untreated pneumothorax
  4. D.A patient with pulmonary embolism

Correct answer

A patient with chronic COPD

Explanation

Ipratropium is primarily used as a maintenance bronchodilator in COPD.

Question 4Difficulty 1/5

Ipratropium is best described as which type of COPD medication?

  1. A.Maintenance bronchodilator
  2. B.Rescue corticosteroid
  3. C.Mucolytic
  4. D.Pulmonary vasodilator

Correct answer

Maintenance bronchodilator

Explanation

Ipratropium is scheduled maintenance therapy rather than anti-inflammatory therapy.

Question 5Difficulty 1/5

Which COPD therapy commonly includes ipratropium?

  1. A.Maintenance bronchodilator therapy
  2. B.Long-term antibiotic therapy
  3. C.Anticoagulation
  4. D.Pulmonary vasodilator therapy

Correct answer

Maintenance bronchodilator therapy

Explanation

Ipratropium provides scheduled bronchodilation for COPD patients.

Question 6Difficulty 1/5

Ipratropium is commonly added during which acute condition?

  1. A.Severe asthma exacerbation
  2. B.Pulmonary edema
  3. C.Spontaneous pneumothorax
  4. D.ARDS

Correct answer

Severe asthma exacerbation

Explanation

Ipratropium is recommended with albuterol during moderate-to-severe asthma exacerbations.

Question 7Difficulty 2/5

Why is ipratropium added to albuterol during severe exacerbations?

  1. A.Improves bronchodilation
  2. B.Acts as an antibiotic
  3. C.Replaces corticosteroids
  4. D.Reduces pulmonary edema

Correct answer

Improves bronchodilation

Explanation

The two medications work by complementary mechanisms.

Question 8Difficulty 2/5

Intranasal ipratropium primarily treats:

  1. A.Rhinorrhea
  2. B.Nasal polyps
  3. C.Sinus infection
  4. D.Nasal congestion caused by polyps

Correct answer

Rhinorrhea

Explanation

Intranasal ipratropium decreases nasal secretions but does not relieve congestion.

Question 9Difficulty 2/5

Which emergency medication combination is considered standard therapy?

  1. A.Albuterol plus ipratropium
  2. B.Tiotropium plus budesonide
  3. C.Montelukast plus prednisone
  4. D.Theophylline plus cromolyn

Correct answer

Albuterol plus ipratropium

Explanation

Combination SABA + SAMA therapy improves airflow during acute exacerbations.

Question 10Difficulty 2/5

Which inhaled disease state is NOT a primary indication for ipratropium?

  1. A.Idiopathic pulmonary fibrosis
  2. B.COPD
  3. C.Bronchospasm
  4. D.Asthma exacerbation adjunct

Correct answer

Idiopathic pulmonary fibrosis

Explanation

Ipratropium has no established role in pulmonary fibrosis.

Question group

Contraindications, Safety, and Interactions

10 questions
Question 1Difficulty 1/5

Which patient should NOT receive ipratropium due to an absolute contraindication?

  1. A.Hypersensitivity to ipratropium
  2. B.Stable COPD
  3. C.Controlled hypertension
  4. D.Former smoker

Correct answer

Hypersensitivity to ipratropium

Explanation

Hypersensitivity to ipratropium or atropine derivatives is an absolute contraindication.

Question 2Difficulty 1/5

Patients should discontinue ipratropium immediately if they develop:

  1. A.Signs of anaphylaxis
  2. B.Mild dry mouth
  3. C.Transient cough
  4. D.Mild bitter taste

Correct answer

Signs of anaphylaxis

Explanation

Anaphylaxis requires immediate discontinuation and emergency treatment.

Question 3Difficulty 1/5

Which eye disorder requires caution with nebulized ipratropium?

  1. A.Narrow-angle glaucoma
  2. B.Cataracts
  3. C.Macular degeneration
  4. D.Diabetic retinopathy

Correct answer

Narrow-angle glaucoma

Explanation

Accidental ocular exposure may precipitate acute angle-closure glaucoma.

Question 4Difficulty 1/5

Which urinary condition may worsen with ipratropium?

  1. A.Benign prostatic hyperplasia
  2. B.Kidney stones
  3. C.Urinary tract infection
  4. D.Nephrotic syndrome

Correct answer

Benign prostatic hyperplasia

Explanation

Anticholinergic medications may increase urinary retention.

Question 5Difficulty 1/5

Direct nebulizer spray into the eyes may cause:

  1. A.Acute angle-closure glaucoma
  2. B.Retinal detachment
  3. C.Corneal ulcer
  4. D.Conjunctivitis

Correct answer

Acute angle-closure glaucoma

Explanation

Avoid facial masks that leak aerosol toward the eyes.

Question 6Difficulty 2/5

If breathing suddenly worsens immediately after ipratropium administration, suspect:

  1. A.Paradoxical bronchospasm
  2. B.Normal medication response
  3. C.Delayed bronchodilation
  4. D.Drug tolerance

Correct answer

Paradoxical bronchospasm

Explanation

Paradoxical bronchospasm is rare but potentially life-threatening.

Question 7Difficulty 2/5

Which condition is considered a precaution rather than a common side effect?

  1. A.Narrow-angle glaucoma
  2. B.Dry mouth
  3. C.Bitter taste
  4. D.Mild cough

Correct answer

Narrow-angle glaucoma

Explanation

Glaucoma is an important clinical precaution because ocular exposure can trigger an emergency.

Question 8Difficulty 2/5

Which patient should be monitored closely for urinary retention?

  1. A.A man with enlarged prostate
  2. B.A patient with asthma
  3. C.A patient with pneumonia
  4. D.A patient with pulmonary fibrosis

Correct answer

A man with enlarged prostate

Explanation

Anticholinergic effects may worsen bladder outlet obstruction.

Question 9Difficulty 2/5

Which allergy should immediately make you question an ipratropium order?

  1. A.Previous anaphylaxis to atropine derivatives
  2. B.Penicillin allergy
  3. C.Shellfish allergy
  4. D.Sulfa allergy

Correct answer

Previous anaphylaxis to atropine derivatives

Explanation

Ipratropium is contraindicated in patients with hypersensitivity to atropine derivatives.

Question 10Difficulty 3/5

Which older formulation historically required caution in peanut allergy?

  1. A.Older CFC Atrovent inhalers
  2. B.Current Atrovent HFA
  3. C.DuoNeb
  4. D.Combivent Respimat

Correct answer

Older CFC Atrovent inhalers

Explanation

Older formulations contained soy lecithin; modern HFA products do not.

Question group

Adverse Effects

12 questions
Question 1Difficulty 1/5

Which adverse effect is expected rather than allergic?

  1. A.Dry mouth
  2. B.Facial swelling
  3. C.Angioedema
  4. D.Anaphylaxis

Correct answer

Dry mouth

Explanation

Dry mouth is a predictable pharmacologic effect rather than hypersensitivity.

Question 2Difficulty 1/5

Which side effect is most directly related to reduced salivary secretion?

  1. A.Dry mouth
  2. B.Hypotension
  3. C.Bronchospasm
  4. D.Peripheral edema

Correct answer

Dry mouth

Explanation

Muscarinic blockade decreases salivary gland secretion.

Question 3Difficulty 1/5

Which respiratory adverse event requires immediate discontinuation?

  1. A.Paradoxical bronchospasm
  2. B.Mild cough
  3. C.Dry throat
  4. D.Hoarseness

Correct answer

Paradoxical bronchospasm

Explanation

Paradoxical bronchospasm is rare but life-threatening.

Question 4Difficulty 1/5

Which adverse effect may occur if nebulized ipratropium contacts the eyes?

  1. A.Blurred vision
  2. B.Hearing loss
  3. C.Tinnitus
  4. D.Vertigo

Correct answer

Blurred vision

Explanation

Ocular exposure can produce blurred vision and glaucoma symptoms.

Question 5Difficulty 1/5

Patients frequently complain of what unpleasant taste after using ipratropium?

  1. A.Bitter taste
  2. B.Sweet taste
  3. C.Metallic blood taste
  4. D.Complete loss of taste

Correct answer

Bitter taste

Explanation

A bitter or unpleasant taste is commonly reported.

Question 6Difficulty 1/5

What is the most common adverse effect of inhaled ipratropium?

  1. A.Dry mouth
  2. B.Hypokalemia
  3. C.Hyperglycemia
  4. D.Bradycardia

Correct answer

Dry mouth

Explanation

Dry mouth is the classic anticholinergic adverse effect.

Question 7Difficulty 2/5

Which upper-airway symptom commonly occurs because of inhaled anticholinergic therapy?

  1. A.Dry throat
  2. B.Hemoptysis
  3. C.Stridor
  4. D.Pulmonary edema

Correct answer

Dry throat

Explanation

Local anticholinergic effects may produce throat dryness.

Question 8Difficulty 2/5

Which gastrointestinal complaint may occur because of anticholinergic activity?

  1. A.Nausea
  2. B.GI bleeding
  3. C.Pancreatitis
  4. D.Severe diarrhea

Correct answer

Nausea

Explanation

Mild nausea and dyspepsia have been reported.

Question 9Difficulty 2/5

Which cardiovascular symptom occasionally occurs with ipratropium?

  1. A.Tachycardia
  2. B.Complete heart block
  3. C.Pulseless electrical activity
  4. D.Severe hypertension

Correct answer

Tachycardia

Explanation

Tachycardia is uncommon but may occur, especially with beta-agonists.

Question 10Difficulty 2/5

Which nasal complaint is commonly reported with intranasal ipratropium?

  1. A.Nasal dryness
  2. B.Massive epistaxis
  3. C.Anosmia
  4. D.Sinus abscess

Correct answer

Nasal dryness

Explanation

Intranasal ipratropium commonly causes dryness and irritation of the nasal mucosa.

Question 11Difficulty 2/5

Which serious urinary adverse effect is associated with ipratropium?

  1. A.Urinary retention
  2. B.Polyuria
  3. C.Hematuria
  4. D.Proteinuria

Correct answer

Urinary retention

Explanation

Anticholinergic medications can impair bladder emptying.

Question 12Difficulty 2/5

Which symptom may indicate acute angle-closure glaucoma after ipratropium exposure?

  1. A.Eye pain with halos around lights
  2. B.Watery eyes
  3. C.Color blindness
  4. D.Floaters

Correct answer

Eye pain with halos around lights

Explanation

These symptoms require urgent ophthalmologic evaluation.

Question group

Clinical Scenarios and NBRC Reasoning

10 questions
Question 1Difficulty 1/5

A patient asks if Atrovent can replace their rescue albuterol inhaler during sudden dyspnea. What is the best response?

  1. A.No, albuterol remains the primary rescue bronchodilator.
  2. B.Yes, ipratropium works faster.
  3. C.Yes, ipratropium replaces all rescue therapy.
  4. D.Yes, but only at double doses.

Correct answer

No, albuterol remains the primary rescue bronchodilator.

Explanation

Ipratropium is primarily a maintenance bronchodilator and adjunct during severe exacerbations.

Question 2Difficulty 1/5

An asthma patient receives repeated DuoNeb treatments during the first hour. Which medication provides the anticholinergic effect?

  1. A.Ipratropium
  2. B.Albuterol
  3. C.Magnesium sulfate
  4. D.Prednisone

Correct answer

Ipratropium

Explanation

DuoNeb combines albuterol with ipratropium for additive bronchodilation.

Question 3Difficulty 1/5

A COPD patient arrives to the ED with diffuse wheezing. Which medication should be added to nebulized albuterol to improve bronchodilation?

  1. A.Ipratropium
  2. B.Montelukast
  3. C.Budesonide
  4. D.Acetylcysteine

Correct answer

Ipratropium

Explanation

Combined SABA + SAMA therapy is standard initial treatment for moderate-to-severe COPD exacerbations.

Question 4Difficulty 1/5

Which patient is the BEST candidate for scheduled inhaled ipratropium?

  1. A.A patient with stable COPD requiring maintenance bronchodilation
  2. B.A patient with acute pulmonary embolism
  3. C.A patient with untreated pneumothorax
  4. D.A patient with pulmonary fibrosis

Correct answer

A patient with stable COPD requiring maintenance bronchodilation

Explanation

Ipratropium is indicated for maintenance treatment of COPD bronchospasm.

Question 5Difficulty 2/5

A man with severe BPH develops difficulty urinating after starting ipratropium. Which medication effect is responsible?

  1. A.Anticholinergic urinary retention
  2. B.Renal toxicity
  3. C.Diuretic effect
  4. D.Beta-2 stimulation

Correct answer

Anticholinergic urinary retention

Explanation

Muscarinic blockade can impair bladder emptying.

Question 6Difficulty 2/5

Which inhaled medication should generally replace ipratropium for long-term once-daily COPD maintenance?

  1. A.Tiotropium
  2. B.Albuterol
  3. C.Levalbuterol
  4. D.Epinephrine

Correct answer

Tiotropium

Explanation

LAMA therapy provides superior long-duration maintenance bronchodilation.

Question 7Difficulty 2/5

A patient experiences immediate worsening wheezing after inhaling ipratropium. What is the most likely explanation?

  1. A.Paradoxical bronchospasm
  2. B.Normal medication response
  3. C.Delayed onset of action
  4. D.Tolerance

Correct answer

Paradoxical bronchospasm

Explanation

Although rare, paradoxical bronchospasm requires immediate discontinuation of the medication.

Question 8Difficulty 2/5

During an asthma exacerbation, why is ipratropium combined with albuterol?

  1. A.The drugs work through complementary mechanisms.
  2. B.They prevent pneumonia.
  3. C.They reduce pulmonary edema.
  4. D.They eliminate the need for corticosteroids.

Correct answer

The drugs work through complementary mechanisms.

Explanation

Beta-2 agonism plus muscarinic blockade produces greater bronchodilation than either medication alone.

Question 9Difficulty 2/5

A respiratory therapist notices aerosol escaping around a nebulizer mask toward the patient's eyes. What should be done?

  1. A.Prevent aerosol exposure to the eyes.
  2. B.Increase nebulizer flow.
  3. C.Remove the mouthpiece.
  4. D.Increase medication dose.

Correct answer

Prevent aerosol exposure to the eyes.

Explanation

Eye exposure increases the risk of glaucoma and blurred vision.

Question 10Difficulty 2/5

A patient accidentally sprays Atrovent into both eyes and now complains of halos and severe eye pain. What complication should you suspect?

  1. A.Acute angle-closure glaucoma
  2. B.Retinal detachment
  3. C.Conjunctivitis
  4. D.Corneal abrasion

Correct answer

Acute angle-closure glaucoma

Explanation

Nebulized or inhaled ipratropium reaching the eyes can precipitate angle-closure glaucoma.

Related study paths

Continue building pharmacology mastery

Use this medication page as a reference, then reinforce it with interactive practice and related PulmTools study resources.

Browse respiratory pharmacologyPharmaGenius quizPulmTools learn library